Merck & Co. Inc. (MRK) Stock Quote

Detailed Quote for Merck & Co. Inc. (MRK)

After Hours: $ 38.05

0.14 (+0.37%)

Volume: 285.64 k

5:20 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

January 19, 2012

Close: 39.43

52 Week Low

August 9, 2011

Close: 29.47

Today

Last Price
37.91

Change $
0.24

Change %
0.63%

Tick
N/A

Bid
36.50

Bid Size
100

Ask
N/A

Ask Size
0

Open
37.94

High
38.01

Low
37.78

Prev Close
38.15

Last Trade
2/10/12

Volume
10.52 m

52 Wk Hi
39.43

52 Wk Low
29.47

Market Cap
115.55 b

Ex-Div Date
12/13/11

Div Rate
1.68

Yield
4.4315

Shares
3,047,921,407

EPS (TTM)
2.02

PE Ratio
18.80

close Exchange Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for Merck & Co. Inc. (MRK)

Sector News | Topic News

News for MRK

Wed, Feb 08, 2012

3:00 PM

Thomas E. Shenk To Retire From Merck's Board of Directors - Business Wire

Tue, Feb 07, 2012

9:00 AM

Perception, Opportunity in Volatility - Research & Analysis on Human Genome Sciences and Merck & Co., Inc. - Marketwire

8:30 AM

Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar - Business Wire

Mon, Feb 06, 2012

8:45 AM

Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia - Business Wire

Thu, Feb 02, 2012

2:44 PM

FDA Approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of JANUMET® (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience - Business Wire

7:00 AM

Merck Announces Full-Year and Fourth-Quarter 2011 Financial Results - Business Wire

Thu, Jan 26, 2012

8:00 AM

Reminder: Merck to Hold 2011 Full-Year and Fourth-Quarter Sales and Earnings Conference Call on February 2 - Business Wire

Wed, Jan 25, 2012

8:30 AM

New FDA Approved Labeling For VYTORIN® (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease - Business Wire

Mon, Jan 23, 2012

9:00 AM

2012 Economic Outlook - Report Highlights Merck & Co., Inc. and AstraZeneca plc (ADR) - Marketwire

Thu, Jan 19, 2012

4:46 PM

Merck Resolves Vioxx® Litigation in Canada - Canada Newswire

Wed, Jan 18, 2012

8:20 AM

Positive Sentiment Returns to GlaxoSmithKline and Merck - Marketwire

Mon, Jan 09, 2012

8:30 AM

Merck to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire

Wed, Jan 04, 2012

8:30 AM

Merck to Present at Goldman Sachs 2012 Healthcare Event - Business Wire

Mon, Jan 02, 2012

8:16 AM

Big Pharma Responds to Mounting Regulatory and Patent Pressures - Marketwire

Wed, Dec 21, 2011

11:19 AM

Merck and the ADAP Crisis Task Force Announce New Agreement to Improve Access and Care for People with HIV - Business Wire

Tue, Dec 06, 2011

1:30 AM

Merck Establishes New MSD R&D Asia Headquarters - Business Wire

Tue, Nov 22, 2011

7:56 PM

Merck to pay Vioxx fine, claims of $950M - UPI

3:23 PM

Merck Resolves Previously Disclosed Seven-Year Investigation Led by U.S. Attorney's Office for the District of Massachusetts Related to Vioxx® - Business Wire

Mon, Nov 21, 2011

9:01 AM

Steps in the Right Direction - Featured Research on Miller Energy Resources Inc and Merck & Co., Inc. - Marketwire

Sat, Nov 12, 2011

1:41 AM

Penn State students hold vigil for victims - UPI

More News for MRK >>

Tags for Merck & Co. Inc.

Research stocks or mutual funds related to Merck & Co. Inc. by keywords or tags. Find companies that have a similar focus to MRK. The keywords below have been associated to MRK by either user submission or electronic means.

biotechnology company medicare reimbursement merck and co merck salary merck openings medicare part d gov merck schering plough pharmaceuticals patient assistance program senior health care dna vaccines merck work pharmaceutical market merck manual generic pharmaceutical medicare vs medicaid canadian health insurance niche pharmaceutical medicare part d health insurance survey merck vet manual texas medicare pharmaceutical research and development mmr vaccine biotech jobs medicare health pharmaceutical manufacturing company rabies vaccines rabies vaccine dupont pharmaceuticals merk stock merck internship pharma marketing merck co merck sharp medicaid medicare premiums merck headquarters merck corporate merck contract pfizer pharmaceutical company kv pharmaceutical company canadian health care medicare coverage biotechnology jobs uninsured health pharmaceutical cro pharma companies combination vaccines merck hpv vaccine storage